Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
105.38 x 2 106.52 x 1
Post-market by (Cboe BZX)
105.35 -0.76 (-0.72%) 02/18/25 [NYSE]
105.38 x 2 106.52 x 1
Post-market 105.38 +0.03 (+0.03%) 16:46 ET
Profile for Tue, Feb 18th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Boston Scientific Corp 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752 USA

www.bostonscientific.com Employees: 48,000 P: 508-683-4000 F: 508-650-8923

Sector:

Medical

Description:

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

Key Statistics

Overview:

Market Capitalization, $K 156,387,792
Enterprise Value, $K 164,624,800
Shares Outstanding, K 1,473,827
Annual Sales, $ 16,747 M
Annual Net Income, $ 1,854 M
Last Quarter Sales, $ 4,561 M
Last Quarter Net Income, $ 566,000 K
EBIT, $ 3,457 M
EBITDA, $ 4,711 M
60-Month Beta 0.80
% of Insider Shareholders 0.50%
% of Institutional Shareholders 89.07%
Float, K 1,466,458
% Float 99.50%
Short Volume Ratio 0.18

Growth:

1-Year Return 60.06%
3-Year Return 133.59%
5-Year Return 181.76%
5-Year Revenue Growth 56.00%
5-Year Earnings Growth 58.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.70 on 02/05/25
Next Earnings Date N/A
Earnings Per Share ttm 2.51
EPS Growth vs. Prev Qtr 11.11%
EPS Growth vs. Prev Year 27.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 11/06/03

BSX Ratios

Ratio
Price/Earnings ttm 42.29
Price/Earnings forward 37.26
Price/Earnings to Growth 2.81
Return-on-Equity % 18.11%
Return-on-Assets % 9.99%
Profit Margin % 11.07%
Debt/Equity 0.52
Price/Sales 9.34
Price/Cash Flow 34.15
Price/Book 7.46
Book Value/Share 14.22
Interest Coverage 8.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion